MedTech’s New Normal: More Regulatory, Pricing Pressures And Challenging Financing Climate
This article was originally published in The Gray Sheet
Executive Summary
Sustaining innovation in the current policy and financing environment may require new strategies from device companies focused not just on developing new products but on expanding into new kinds of offerings, including services and “holistic” solutions, Ernst & Young concludes in a recent report.